ACCP Announces 2020 - 2022 Officers
The American College of Clinical Pharmacology ® is pleased to announce its newly-elected 2020 - 2022 Officers. These members of the Executive Committee will work closely with the ACCP Board of Regents to support ACCP's Mission and Vision and to provide leadership and guidance as ACCP continues to achieve its strategic organizational goals and enhance the Member experience. Please join ACCP in congratulating its new Officers!
Donald E. Mager, PharmD, PhD, FCP

Dr. Mager has been a Member of ACCP since 2004 and was named a Fellow in 2009. In 2013, Dr. Mager was elected to the ACCP Board of Regents and currently serves as President Elect on the Executive Committee. He also served as a Co-guest Editor for a supplemental issue of  The Journal of Clinical Pharmacology  on Biologics in 2015 and is on the Editorial Board of  Clinical Pharmacology in Drug Development. He served on the 2013 Annual Meeting Program Committee, was Chair of the Finance Committee in 2014 - 2016, served as Treasurer in 2016-2018 and currently serves as Chair of the Nominating Committee. 
Dr. Mager is Professor and Vice Chair of Pharmaceutical Sciences at the Univ at Buffalo, State Univ of New York and a member of the graduate faculty at Roswell Park Comprehensive Cancer Ctr in Buffalo, NY. He also served as a Visiting Professor at the Univ Paris Descartes in January from 2007 - 2013, 2016, 2019 and 2020. He has served on the Pharmaceutical Sciences and Clinical Pharmacology Advisory Committee to the FDA and is on the Editorial Advisory Boards of several journals. Dr. Mager also serves as an Associate Editor at CPT:PSP. He is a former Past President of the Int'l Society of Pharmacometrics, is an expert member of the Board of Pharmaceutical Sciences at FIP and is a Fellow of ISoP, AAPS and AAAS. His research focuses on identifying molecular and physiological factors that control the pharmacological properties of drugs, with a focus on anti-cancer and immunomodulatory agents. Dr. Mager has contributed to over 140 peer-reviewed publications.
President Elect
Richard C. Brundage, PharmD, PhD, FCP

Dr. Brundage has been an ACCP Member since 2007 and became a Fellow in 2016. He was elected to ACCP's Board of Regents in 2018 and currently chairs the Credentials Committee. Dr. Brundage was an active member of the 2019 ACCP Annual Meeting Program Committee and in 2016 was the recipient of the ACCP Bristol-Myers Squibb Mentorship in Clinical Pharmacology Award.

Dr. Brundage is a Professor in the Dept of Experimental & Clinical Pharmacology at the Univ of Minnesota, Coll of Pharmacy and has been teaching Applied Pharmacokinetics in the professional program and Pharmacometrics & Population Pharmacokinetics in the graduate program since 2002. His research interests involve the quantitative modeling of pharmacological systems for the purpose of better understanding dose-response relationships. These pharmacometric analyses have been applied to infectious disease, epilepsy, cardiovascular and transplantation areas. One of the therapeutic areas of particular interest involves improving the treatment of children diagnosed with congenital adrenal hyperplasia (CAH). A current initiative is to evaluate the pharmacokinetic/pharmacodynamic relationships among cortisol, 17-hydroxyprogesterone and androstenedione in conjunction with a pulsatile subcutaneous hydrocortisone therapy using a pump in pediatric patients with CAH. Dr. Brundage has received a Meritorious Manuscript Award from AAPS; the Award for Outstanding Contributions to Graduate and Professional Education from the Univ of Minnesota; the Outstanding Adviser Award from the Graduate & Professional Student Association and was inducted in the inaugural cohort of Fellows in the Int'l Society of Pharmacometrics. He was a founding Board of Directors member of the Int'l Society of Pharmacometrics. 
Oliver Grundmann, PhD, FCP

In 2006, Dr. Grundmann joined ACCP as a Student Member and became a Member in 2007 and a Fellow in 2016. He was elected to the ACCP Board of Regents in 2020 and has been a member of the Student, Trainee & Early-stage Professional (STEP) Committee since 2014 which he currently co-chairs. During his tenure on the STEP Committee, Dr. Grundmann has supported and worked to execute a number of changes that support young colleagues and encourage early-stage professionals to engage further with ACCP to both their benefit and the benefit of ACCP.

Dr. Grundmann obtained his BPharm from the Westfälische-Wilhelms-Univ in Münster in 2004 before being offered to continue his graduate studies in Pharmaceutical Sciences as a Gator at the Univ of Florida (UF). While completing his PhD he satisfied his curiosity in the area of Forensic Toxicology by obtaining a MSc with a minor in Statistics. His postdoctoral work in the area of radiation biology and salivary gland damage brought him to the Univ of Arizona in Tucson. However, his passion for teaching and research on natural products with CNS activity ultimately led him back to his Alma mater at UF where he is now Clinical Associate Professor & Director, Medicinal Chemistry, Coll of Pharmacy. Dr. Grundmann is fortunate to collaborate with many great minds both on the national and international level in the pre-clinical and clinical stages to investigate the pharmacology, phytochemistry and epidemiology of natural products such as Kratom and Iberogast.
Navin S. Goyal, PhD, FCP

Dr. Goyal joined ACCP as a Student Member in 2007, became a Member in 2010 and has been a Fellow since 2016. He was elected to the ACCP Board of Regents in 2020. He was a member of the ACCP Honors and Awards Committee (2014-2019) and the 2019 ACCP Annual Meeting Program Committee.
Dr. Goyal is currently a Director in Clinical Pharmacology at GlaxoSmithKline (GSK), Pennsylvania. He earned his PhD in Pharmaceutics in 2009 from the Univ of Florida. Thereafter, he started at the Clinical Pharmacology, Modeling & Simulation group at GSK. Dr. Goyal’s primary role involves application of principles and quantitative techniques in clinical pharmacology to aid drug development spanning from early clinical studies through registration and beyond. He has supported and published his research in clinical pharmacology and pharmacometrics across multiple therapy areas including respiratory, CNS, cardiovascular and infectious diseases. Apart from his day job, Dr. Goyal continues to mentor student interns, postdoctoral fellows and scientists within his group at GSK and through external collaborations. He holds an adjunct faculty appointment in the Dept of Pharmaceutics at Univ of Florida and is also a faculty for the Pharmacometrics Program at Univ of North Texas, Health Science Ctr. Along with ACCP, Dr. Goyal is also involved in other allied organizations such as International Society of Pharmacometrics (ISoP).
Immediate Past President
Vikram Arya, PhD, FCP

Dr. Arya joined ACCP in 2002 as a Student Member, became a Member in 2004 and a Fellow in 2005. During his membership in ACCP, he has actively contributed towards the mission of the society. He was an instrumental member of the Board of Regents from 2009 - 2014, served as Secretary in 2015 - 2016 and President Elect in 2017-2018 and is currently serving as President of the Executive Committee. Dr. Arya was an ACCP Student Abstract Award Winner in 2002. His many contributions include formulating and initiating the Student Outreach Initiative, Co-chair of the Annual Meeting Program Committee in 2010, 2013 and 2016, serving on the Editorial Board of The Journal of Clinical Pharmacology (JCP) and serving as Co-editor of two special supplementary issues of JCP. He was actively involved on the Membership Committee from 2005 - 2010.

Dr. Arya is a Clinical Pharmacology Team Leader in the Office of Clinical Pharmacology (OCP), Center for Drug Evaluation and Research (CDER), FDA. He is primarily responsible for providing technical and strategic leadership to a group of scientists who review the clinical pharmacology aspects of regulatory submissions and contribute to the benefit/risk assessment of antiviral drugs. He is the recipient of the FDA Outstanding Service Award, FDA Leveraging and Collaboration Award and several CDER Regulatory Science Excellence and Team Excellence Awards to recognize his contributions to review and active participation in a variety of regulatory science and policy setting initiatives. 

Dr. Arya holds an Adjunct Clinical Professor appointment in the Dept of Pharmacy Practice at Mercer Univ, Atlanta, GA, Adjunct Assistant Professor appointment in the Dept of Pharmaceutical Sciences at the Univ of Tennessee, Adjunct Associate Professor appointment in the Dept of Pharmaceutics, Univ of Florida and Adjunct Professor appointment in the Dept of Pharmacotherapy in the Univ of North Texas System Coll of Pharmacy.
John van den Anker, MD, PhD, FCP

 Dr. van den Anker has served ACCP since joining as a Fellow in 2002 and is currently the Immediate Past President of the Executive Committee. He became a member of the Board of Regents in 2010 and served as Secretary in 2013 - 2014, President Elect in 2015 - 2016 and assumed the Presidency in 2017 - 2018. Presently, he is a member of the ByLaws Committee and served as Chair of the Nominating Committee from 2014 - 2016. Dr. van den Anker has also served on the 2016, 2017 & 2018 Annual Meeting Program Committees and was a member of Strategic Vision Committee from 2011 - 2014.
Dr. van den Anker is the Evan and Cindy Jones Endowed Chair of Pediatric Clinical Pharmacology, Vice Chair of Pediatrics for Experimental Therapeutics and Chief of the Div of Pediatric Clinical Pharmacology at Children's National Hosp in Washington, DC. He is Professor of Pediatric, Pharmacology & Physiology and Genomics & Precision Medicine at the George Washington Univ School of Medicine and Health Sciences. Dr. van den Anker is currently also the Eckenstein-Geigy Distinguished Professor of Pediatric Pharmacology and Chair of the Dept of Pediatric Pharmacology & Pharmacometrics at the Univ Children’s Hosp Basel, Univ of Basel in Switzerland. Dr. van den Anker has published over 450 peer reviewed papers in the field of neonatal and pediatric clinical pharmacology and serves on The Journal of Clinical Pharmacology Editorial Board.
ACCP is a Member-focused/Member-driven clinical pharmacology society with 
Member Benefits  that enhance your professional growth.  Join today!
Stay Connected